
PM · NYSE
The supplied consensus is Buy across 15 analysts. Its stated target low and high are both $215, with a $214.50 mean; that mean is below the stated low, so the target summary is internally inconsistent and does not establish a meaningful range. Argus Research is the most bullish named analyst in the evidence, with a $220 target after raising it from $210 on October 26. The least-bullish target is $215 in the consensus summary, but no analyst is named for it. The only explicitly reported revision during the week is upward, from Argus; the evidence does not identify broader weekly revisions or explain the valuation gap beyond Argus’s higher projected value.
| Firm | Analyst | Rating | Price Target | Upside | Date | Source |
|---|---|---|---|---|---|---|
| Morgan Stanley | — | $215 | +3.6% | Jul 23, 2026 | Open the report this row came from |